Home / Companies / Sichuan Kelun Pharmaceutical Co., Ltd. / 19 May 2025
Sichuan Kelun Pharmaceutical Co., Ltd.: meeting of 19 May 2025
Votes reported on Form N-PX, item by item
36 Form N-PX filers reported votes at the Sichuan Kelun Pharmaceutical Co., Ltd. meeting of 19 May 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
62 vote records from 36 filers. 1 of the 36 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
68 vote records from 34 filers. 24 of the 34 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
180 vote records from 36 filers. 23 of the 36 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
224 vote records from 30 filers. 0 of the 30 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
24 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Auditor |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | For |
| State Street and SPDR | For |
| Franklin Templeton | For |
| Charles Schwab | For |
| Nuveen and TIAA | For |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| J.P. Morgan | For |
| WisdomTree | For |
| Jackson National funds | For |
| Northern Trust and FlexShares | For |
| SEI | For |
| Lincoln Financial | For |
| BNY Mellon | For |
| Pacific Life funds | For |
| AllianceBernstein | Abstain or withhold * |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Sichuan Kelun Pharmaceutical Co., Ltd. meeting?
36 Form N-PX filers reported votes at the meeting of 19 May 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sichuan Kelun Pharmaceutical Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Sichuan Kelun Pharmaceutical Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sichuan Kelun Pharmaceutical Co., Ltd. with a meeting date within three days of 19 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.